NCT07325214 2026-01-12
Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer
IMGT Co., Ltd.
Phase NA Not yet recruiting
Clinical Trials
5 trialsNCT01771146 2017-01-31
Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease Cancer
Baylor Research Institute
Phase NA Unknown
NCT01411072 2014-10-03
Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer
AHS Cancer Control Alberta
Phase NA Unknown
NCT01760694 2014-08-15
Multi-Modality Therapy for Untreated Patients With Resectable or Marginally Resectable Pancreatic Cancer
Southwestern Regional Medical Center
Phase NA Terminated
NCT00079365 2013-12-04
Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas
National Cancer Institute (NCI)
Phase NA Unknown